6[1]Fleming GA,Craven DE.Risk factors for nosocomial pneumonia focus on prophylaxia[J].Med clin North Am,2001,85(8):1545-1563.
7[4]Ferrara AM,Fietta AM.New developments in antibacterial choice for lower respiratory infections in elderly patients[J].Drugs Aging,2004,9(3):167-186.
8Gales AC,Jones RN,Turnidge J,et al.Characterization of Pseudomonas aeruginosa isolates:occurrence rates,antimicrobial susceptibility patterns,and molecular typing in the global SENTRY antimicrobial surveillance program[J].Cin Infect Dis,2001,32(2):146.
9Snydman DR,Jacobus NV,Mc Dermott LA,et al.Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens[J].Antimicrob Agents Chemother,2000,44:3447.
10Farra A,Islam S,Stralfors A,et al.Role of outer membrahe protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem[J].Antimicrobial Agents,2007,12(16):365.
